SI
BIIB icon

SII Investments’s Biogen BIIB Stock Holding History

SII Investments’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-987
Closed -$270K – 603
2017
Q1 		$270K Buy
987
+160
+19% +$45.2K 0.02% 495
2016
Q4 		$236K Sell
827
-16
-2% -$4.74K 0.02% 508
2016
Q3 		$265K Buy
+843
New +$250K 0.02% 462
2016
Q2 		– Sell
-839
Closed -$218K – 586
2016
Q1 		$218K Buy
+839
New +$222K 0.02% 507

Other funds holding BIIB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

SII Investments's BIIB Position: Q2 2017 in Review

SII Investments sold out of Biogen (BIIB) in Q2 2017, closing a stake of 987 shares — an estimated $270K sold.

SII Investments first reported a position in BIIB in Q1 2016 and held it in 4 quarters. The position peaked at $270K in Q1 2017. 992 funds tracked by Wall St. Rank hold BIIB as of Q2 2017.

  • SII Investments reported no remaining Biogen position as of Q2 2017 after selling out during the quarter.
  • SII Investments sold 987 Biogen shares in Q2 2017, an estimated $270K.
  • SII Investments first reported a position in Biogen in Q1 2016 and held it in 4 quarters.
  • SII Investments's Biogen position peaked at $270K in Q1 2017.
  • 992 funds tracked by Wall St. Rank held Biogen as of Q2 2017.

Based on SII Investments's 13F filing for Q2 2017, filed 14 Aug 2017.